David Perna‐Barrull

Liposome-Based Immunotherapy Against Autoimmune Diseases: Therapeutic Effect on Multiple Sclerosis

Irma Pujol‐Autonell, Maria-Jose Mansilla, Silvia Rodríguez-Fernández et al. · Nanomedicine · 2017 · 76 citations · Full text

Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry

Silvia Rodríguez-Fernández, Irma Pujol‐Autonell, Ferran Briansó et al. · Frontiers in Immunology · 2018 · 74 citations · Full text

Dcs Viability, Immunology, Immune Regulation +24

NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes

Laia Gómez-Muñoz, David Perna‐Barrull, Adrian Villalba et al. · Frontiers in Immunology · 2021 · 31 citations · Full text

Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes

Adrian Villalba, Silvia Rodríguez-Fernández, Rosa-Maria Ampudia et al. · Artificial Cells Nanomedicine and Biotechnology · 2019 · 27 citations · Full text

Nanoparticles, Nanotherapeutics, Engineering +23

Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming

Adrian Villalba, Silvia Rodríguez-Fernández, David Perna‐Barrull et al. · Frontiers in Endocrinology · 2020 · 22 citations · Full text